Grant: Discovery Grants Program - Individual
University of Toronto
$29,000.00
Spatial and topological control of receptor signaling using DNA nanotechnology
EF 2022-23
Résumé
The Chou group's research program explores design principles of self-assembling nanoscale devices. We currently focus on developing DNA as a medium for 3D nanofabrication, and on functionalizing engineered DNA nanostructures with lipids, polymers, proteins to interface them with biological systems. These DNA-scaffolded nanostructures are unique among synthetic nanomaterials in that their properties are sequence-programmable, which enables exquisite control over their structure and dynamics. Our group is using these capabilities to construct nanodevices that interface with cell membrane receptors for manipulating cell signaling pathways. Of particular interest to us are signaling pathways triggered through large-scale contacts, such as cell-cell and cell-pathogen interactions. These interactions induce cell activation states distinct from those induced using soluble ligands, but are especially difficult to recapitulate synthetically because they involve hetero-multivalent receptor-ligand interactions as well as their drastic spatial re-organization on the plasma membrane. Leveraging the programmability of DNA nanotechnology, this NSERC proposal aims to build an artificial cell membrane capable of spatial control over such multivalent receptor-ligand interactions. The specific aims are to: (1) establish the methodology of manufacturing an artificial cell membrane by combining DNA nanostructures with lipids, polymers, proteins, and microspheres; (2) understand how biological fluids, such as serum, influence features of the artificial cell membrane; (3) assess ability of the artificial cell membrane to toggle cell signaling as a function of its design features; (4) demonstrate ability to potentiate cell signaling via display of hetero-multivalent ligand arrays on the artificial cell membrane. The outcome will advance knowledge of cell signaling biology, generate a programmable cell-interfacing material for use by the biophysics, synthetic biology, and biomedical engineering community, and lead to next-generation technologies for cell manufacturing and for directing cell fate ex vivo and in vivo.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-05966
Name nom
Chou, Leo
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME) - Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2020
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Installment
inst:3
Partie
1
Nb partie
5
Application title
Spatial and topological control of receptor signaling using DNA nanotechnology
Application summary
The Chou group's research program explores design principles of self-assembling nanoscale devices. We currently focus on developing DNA as a medium for 3D nanofabrication, and on functionalizing engineered DNA nanostructures with lipids, polymers, proteins to interface them with biological systems. These DNA-scaffolded nanostructures are unique among synthetic nanomaterials in that their properties are sequence-programmable, which enables exquisite control over their structure and dynamics. Our group is using these capabilities to construct nanodevices that interface with cell membrane receptors for manipulating cell signaling pathways. Of particular interest to us are signaling pathways triggered through large-scale contacts, such as cell-cell and cell-pathogen interactions. These interactions induce cell activation states distinct from those induced using soluble ligands, but are especially difficult to recapitulate synthetically because they involve hetero-multivalent receptor-ligand interactions as well as their drastic spatial re-organization on the plasma membrane. Leveraging the programmability of DNA nanotechnology, this NSERC proposal aims to build an artificial cell membrane capable of spatial control over such multivalent receptor-ligand interactions. The specific aims are to: (1) establish the methodology of manufacturing an artificial cell membrane by combining DNA nanostructures with lipids, polymers, proteins, and microspheres; (2) understand how biological fluids, such as serum, influence features of the artificial cell membrane; (3) assess ability of the artificial cell membrane to toggle cell signaling as a function of its design features; (4) demonstrate ability to potentiate cell signaling via display of hetero-multivalent ligand arrays on the artificial cell membrane. The outcome will advance knowledge of cell signaling biology, generate a programmable cell-interfacing material for use by the biophysics, synthetic biology, and biomedical engineering community, and lead to next-generation technologies for cell manufacturing and for directing cell fate ex vivo and in vivo.